Video: Stanley Druckenmiller, Bearish in 2018.
https://youtu.be/G-MlrpoMig0
"What would you need to see to give you the conviction to want to go short?"At the 53:51 mark!
Video: How the Bank of Japan Created a Massive Bubble That Blew Up.
Fascinating video documentary 'Princes of the Yen: Central Bank Truths' with Banking Expert and Oxford Professor Richard Werner. Werner believes that Central...
80% Market Crash Coming. David Hunter. (Video)
https://youtu.be/VNVeJe70U-c
Video: Okay, You Tested Positive for Corona, Now What?
https://youtu.be/vN30emwcNS4
Professor Roger Seheult,...
Video: Mel Gibson Stem Cell Testimonial.
Fascinating Interview with Joe Rogen, Mel Gibson, and Dr. Neil Riordan, Early Pioneer and Stem Cell Expert.
Joe Rogan...
2021 Breakthrough Wearable Tech: Overview on Hapbee (HAPB, HAPBF) and its Vision
LIVE CHART
https://youtu.be/X_DRzL6MAOU
Latest article
Institutional Analyst Newsletter. Citius (CTXR), GeoVax (GOVX.
DERBY WEEKEND - WE'RE HEADED TO TAMPA!HAT'S ON, DRINK'S UPADDING CITIUS PHARMA (CTXR) $0.66, TO WATCHLISTUPDATING GEOVAX LABS (GOVX) $1.43OUR $26...
Adding Citius Pharma (CTXR) $0.66 to 2024 Watch List.
Three Years Since we Last Added Citius (CTXR) to the Watch List, and it Looks Better Than Ever!
Citius Pharmaceuticals (CTXR) Prospectus, Powerpoint & Fact Sheet.
CRANFORD, N.J., April 26, 2024 /PRNewswire/ -- Citius Pharmaceuticals Inc. (Nasdaq: CTXR) ("Citius" or the "Company"), a late-stage biopharmaceutical company dedicated to the development and commercialization...
